penil
squamou
cell
carcinoma
pscc
rel
rare
malign
tumor
worldwid
howev
develop
countri
much
higher
incid
account
malign
men
major
risk
factor
mainli
compris
human
papilloma
viru
infect
phimosi
poor
hygien
involv
local
lymph
node
ln
major
prognost
factor
pscc
main
treatment
pscc
current
partial
radic
penectomi
without
bilater
inguin
dovepress
dovepress
zhou
et
al
lymphadenectomi
along
radiat
chemotherapi
target
therapi
classic
serum
biomark
cea
afp
psa
clinic
use
mani
cancer
howev
suitabl
penil
cancer
serum
creactiv
protein
crp
squamou
cell
carcinoma
antigen
sccag
report
prognost
marker
pscc
howev
largescal
investig
requir
assess
clinic
applic
marker
discoveri
serolog
biomark
would
help
guid
treatment
predict
prognosi
pscc
togeth
laminin
alpha
laminin
beta
laminin
gamma
compos
heterotrimer
basement
membran
compon
laminin
play
import
physiolog
patholog
role
involv
cellular
migrat
adhes
especi
process
tumor
invas
metastasi
report
overexpress
associ
poor
prognosi
numer
cancer
cytoplasm
accumul
oppos
extracellular
deposit
basement
membran
correl
cancer
metastasi
poor
prognosi
interestingli
elev
level
also
detect
peripher
blood
indic
could
novel
cancer
biomark
howev
express
level
clinic
signific
unknown
pscc
studi
found
overexpress
pscc
tissu
facilit
metastasi
cancer
cell
elev
serum
level
predict
poor
diseasespecif
surviv
dss
could
aid
risk
stratif
earlystag
pscc
patient
one
hundr
fourteen
patient
newli
diagnos
pscc
includ
studi
patient
underw
partial
radic
penectomi
without
bilater
inguin
lymphadenectomi
sun
yatsen
univers
cancer
center
sysucc
surgic
specimen
collect
paraffinembed
cryopreserv
liquid
nitrogen
studi
protocol
approv
institut
ethic
board
sysucc
written
inform
consent
obtain
person
patholog
tnm
stage
redetermin
two
pathologist
accord
american
joint
committe
cancer
tnm
stage
system
pscc
clinicopatholog
characterist
present
tabl
sccag
crp
measur
level
measur
use
enzymelink
immunosorb
assay
kit
uscn
life
scienc
wuhan
china
accord
manufactur
protocol
serum
sccag
crp
concentr
measur
depart
molecular
diagnosi
sysucc
surgeri
high
low
level
crp
sccag
distinguish
correspond
cutoff
valu
ngml
crp
mgml
sccag
ngml
cutoff
valu
crp
obtain
receiv
oper
characterist
roc
curv
analysi
wherea
cutoff
valu
sccag
follow
clinic
guidelin
immunohistochemistri
ihc
assay
ihc
assay
conduct
previous
describ
detect
ecadherin
express
tissu
briefli
formalinfix
paraffinembed
tissu
section
deparaffin
rehydr
follow
antigen
retriev
endogen
peroxidas
inactiv
block
slide
incub
sigmaaldrich
co
st
loui
mo
usa
ecadherin
antibodi
cell
signal
technolog
cst
danver
usa
follow
horseradish
peroxidas
hrp
conjug
secondari
antibodi
cst
visual
use
peroxidas
envis
kit
dako
carpinteria
ca
usa
slide
independ
evalu
two
pathologist
determin
percentag
cancer
cell
posit
stain
cell
cytoplasm
stain
consid
posit
cell
membran
stain
posit
ecadherin
figur
accord
definit
use
previou
report
high
level
express
tumor
tissu
defin
tumor
cell
stain
posit
low
level
ecadherin
express
defin
less
tumor
cell
stain
posit
ecadherin
revers
transcript
quantit
polymeras
chain
reaction
rtqpcr
mrna
level
tumor
tissu
detect
rtqpcr
briefli
total
rna
extract
revers
transcrib
use
primescript
tm
master
mix
takara
dalian
china
quantit
pcr
perform
use
sybr
premix
ex
taq
tm
takara
specif
primer
tabl
rel
express
gene
present
normal
gapdh
express
wb
perform
previous
describ
analyz
protein
level
cell
frozen
tissu
briefli
protein
sampl
routin
extract
quantifi
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
transfer
polyvinyliden
difluorid
membran
block
membran
incub
sigmaaldrich
co
ecadherin
ncadherin
vimentin
gapdhspecif
antibodi
cst
follow
incub
hrpconjug
secondari
antibodi
cst
band
visual
clariti
western
ecl
substrat
detect
chemidoc
touch
imag
system
biorad
laboratori
inc
hercul
ca
usa
cell
line
establish
stabl
cell
line
pscc
cell
line
establish
laboratori
hacat
cell
obtain
ca
type
cultur
collect
chines
academi
scienc
shanghai
china
cell
line
maintain
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
thermo
fisher
scientif
waltham
usa
stabl
cell
line
overexpress
silenc
establish
accord
method
describ
previous
briefli
cdna
clone
vector
system
bioscienc
palo
alto
ca
usa
shrna
tabl
insert
vector
sigmaaldrich
co
st
loui
mo
usa
recombin
lentivirus
packag
cell
use
construct
stabl
cell
line
pscc
cell
cultur
plate
indic
time
cell
prolifer
analyz
use
cell
count
assay
dojindo
japan
repres
optic
densiti
nm
od
transwel
assay
use
evalu
migrat
invas
abil
pscc
cell
previous
describ
briefli
cell
cell
rca
cell
seed
boyden
chamber
pore
without
matrigel
coat
bd
bioscienc
san
jose
ca
usa
hour
incub
migrat
invas
assay
respect
cell
lower
surfac
filter
fix
stain
count
microscop
assay
perform
duplic
repeat
three
time
anim
experi
approv
sysucc
institut
anim
care
use
committe
follow
anim
welfar
right
china
male
balbc
nude
mice
week
old
slrc
laboratori
anim
shanghai
china
use
gener
inguin
ln
metastasi
model
describ
previous
two
million
cell
inject
foot
pad
mice
mice
kill
week
inguin
ln
examin
statist
analys
perform
use
spss
statist
softwar
chisquar
test
use
correl
analys
cox
proport
hazard
regress
model
use
calcul
hr
death
kaplanmei
analysi
logrank
test
use
surviv
analysi
roc
curv
analysi
use
calcul
optimum
cutoff
valu
statist
signific
defin
p
upregul
cancer
tissu
serum
pscc
patient
express
significantli
upregul
mrna
level
figur
protein
level
figur
pscc
tissu
compar
pair
normal
epitheli
tissu
moreov
express
higher
ln
metastat
lesion
primari
cancer
tissu
figur
cytoplasm
accumul
pscc
tissu
normal
tissu
ratio
local
pscc
tissu
express
high
level
higher
patient
ln
metastasi
lnmp
ln
metastasisfre
patient
mfp
figur
concentr
markedli
higher
pscc
patient
ln
metastasi
mfp
healthi
agematch
volunt
differ
found
two
latter
group
figur
moreov
level
like
gradual
increas
advanc
n
stage
figur
data
suggest
overexpress
mainli
relat
ln
metastasi
pscc
promot
migrat
invas
ln
metastasi
pscc
cell
investig
reveal
overexpress
significantli
increas
migrat
invas
cell
figur
b
wherea
silenc
significantli
inhibit
migrat
invas
cell
figur
c
moreov
knockdown
significantli
reduc
abil
cell
metastas
inguin
ln
figur
howev
overexpress
knockdown
obvious
affect
prolifer
pscc
cell
figur
taken
togeth
result
indic
may
play
import
role
promot
pscc
cell
migrat
invas
ln
metastasi
express
epitheli
marker
ecadherin
found
downregul
cell
upregul
cell
compar
correspond
control
cell
figur
convers
express
mesenchym
marker
ncadherin
decreas
cell
increas
cell
figur
clinic
data
analysi
reveal
high
level
display
close
correl
low
express
ecadherin
pscc
tissu
high
level
also
correl
low
ecadherin
level
figur
data
suggest
may
promot
emt
facilit
pscc
metastasi
express
close
associ
outcom
pscc
patient
promot
ln
metastasi
relationship
express
clinicopatholog
paramet
investig
pscc
patient
prognosi
patient
estim
result
show
high
level
strongli
correl
patholog
grade
n
stage
stage
tabl
level
also
correl
level
associ
patholog
grade
n
stage
also
stage
tabl
univari
cox
regress
analysi
suggest
sccag
crp
level
along
stage
n
stage
patholog
grade
show
signific
prognost
valu
surviv
tabl
kaplanmei
analysi
suggest
sccag
crp
level
significantli
correl
dss
pscc
howev
patient
high
level
markedli
lower
surviv
rate
high
level
sccag
crp
vs
sccag
crp
figur
furthermor
combin
tn
stage
patholog
grade
potenti
biomark
multivari
cox
regress
analysi
found
among
level
sccag
crp
level
independ
prognost
indic
dss
pscc
patient
tabl
tabl
data
indic
import
risk
factor
dss
pscc
patient
sccag
crp
subgroup
surviv
analysi
perform
evalu
predict
valu
surviv
patient
stratifi
stage
patholog
grade
n
stage
result
show
high
level
indic
high
risk
death
patient
lessadvanc
stage
without
ln
metastasi
n
stage
n
stage
diseas
differ
prognost
valu
among
differ
patholog
grade
classif
tabl
kaplanmei
analysi
demonstr
level
significantli
associ
dss
pscc
patient
n
stage
cumul
surviv
rate
markedli
lower
group
group
vs
vs
n
vs
figur
g
serolog
marker
access
detect
compar
patholog
paramet
although
patholog
indic
import
prognost
factor
especi
n
stage
serum
marker
afp
cea
psa
wide
appli
clinic
practic
adjunct
clinicopatholog
paramet
monitor
tumor
progress
predict
surviv
howev
valuabl
prognost
serolog
factor
identifi
pscc
although
serum
crp
sccag
level
report
predict
postop
recurr
progress
prognosi
pscc
prognost
valu
need
valid
largescal
investig
previou
report
elev
express
detect
numer
malign
cytoplasm
accumul
andor
increas
serum
correl
tumor
metastasi
poor
prognosi
patient
found
express
upregul
demonstr
especi
high
cytoplasm
accumul
pscc
tissu
overexpress
associ
ln
metastasi
pscc
furthermor
level
associ
n
stage
patholog
grade
analyz
patient
relationship
level
n
stage
pscc
patient
also
support
result
vitro
vivo
experi
indic
promot
pscc
cell
metastasi
effect
zhou
et
al
pscc
cell
may
partial
result
emt
pscc
cell
hypothesi
support
previou
report
show
emt
endow
cell
migratori
invas
properti
elev
level
significantli
associ
shorter
dss
pscc
patient
howev
n
stage
patholog
grade
sccag
crp
independ
prognost
factor
accord
multivari
regress
analysi
studi
result
may
accord
lower
hr
sccag
crp
compar
n
stage
patholog
grade
tabl
thu
specul
import
predict
factor
surviv
pscc
patient
sccag
crp
previous
report
potenti
predict
factor
pscc
patient
particular
stratif
analysi
reveal
level
show
predict
valu
dss
patient
earlystag
penil
cancer
patient
n
stage
howev
due
lower
number
patient
stage
analysi
conclud
level
show
predict
valu
earli
tstage
penil
cancer
find
need
investig
larg
cohort
accord
nccn
guidelin
penil
cancer
version
penil
cancer
patient
nonpalp
ln
harbor
micrometastas
sever
predict
factor
risk
stratif
system
evalu
predict
presenc
occult
node
metastasi
howev
factor
system
base
patholog
diagnosi
may
introduc
error
heterogen
tumor
limit
sampl
find
studi
suggest
serum
level
might
use
risk
stratif
patient
might
add
prognost
inform
convent
clinicopatholog
risk
factor
howev
barrier
must
overcom
develop
serolog
index
bench
clinic
first
independ
multicent
largescal
retrospect
studi
necessari
next
prospect
control
clinic
trial
also
need
index
brought
clinic
use
especi
ln
metastasi
predict
treatment
monitor
limit
predict
poor
prognosi
pscc
studi
small
sampl
pscc
patient
singl
center
includ
select
bia
inevit
number
patient
advanc
stage
ln
metastasi
n
lower
number
patient
n
stage
could
confirm
level
predict
valu
dss
pscc
patient
high
stage
ln
metastasi
n
divers
adjuv
therapi
may
also
affect
analysi
given
defici
mention
analys
studi
regard
hypothesi
gener
rather
hypothesi
test
studi
reveal
play
critic
role
pscc
progress
metastasi
elev
level
strongli
correl
advanc
clinicopatholog
paramet
especi
ln
metastasi
pscc
patient
level
might
serv
potenti
prognost
biomark
pscc
patient
especi
earlystag
penil
cancer
especi
patient
n
stage
predict
valu
level
superior
crp
sccag
previous
report
pscc
patient
certainli
studi
base
larg
sampl
multipl
center
need
assess
possibl
clinic
applic
predict
poor
prognosi
pscc
